AimsWe investigated the role of the TLR4-accessory molecule RP105 (CD180) in post-ischemic neovascularization, i.e. arteriogenesis and angiogenesis. TLR4-mediated activation of pro-inflammatory Ly6Chi monocytes is crucial for effective neovascularization. Immunohistochemical analyses revealed that RP105+ monocytes are present in the perivascular space of remodeling collateral arterioles. As RP105 inhibits TLR4 signaling, we hypothesized that RP105 deficiency would lead to an unrestrained TLR4-mediated inflammatory response and hence to enhanced blood flow recovery after ischemia.
展开▼
机译:目的我们研究了TLR4辅助分子RP105(CD180)在缺血后新血管形成(即动脉生成和血管生成)中的作用。 TLR4介导的促炎性Ly6C hi sup>单核细胞的激活对于有效的新血管形成至关重要。免疫组织化学分析表明,RP105 + sup>单核细胞存在于侧枝小动脉重构的血管周围。由于RP105抑制TLR4信号传导,我们假设RP105缺乏会导致不受约束的TLR4介导的炎症反应,从而增强缺血后的血流恢复。
展开▼